Medico Remedies Ltd. (MEDICO) Share Price Surges 9.19% Today

Medico Remedies Ltd. Share Price surged 9.19% today to Rs 41.71, with a market cap of Rs 317 crore.

Medico Remedies Ltd. Share Price experienced a significant rise today, closing at Rs 41.71, marking a 9.19% increase from its previous close of Rs 38.2. This surge positions the company as a top gainer in the micro-cap category, where the qualifying threshold for a notable price rise is set at 8.1%. With a market capitalisation of Rs 317 crore, Medico Remedies Ltd. has captured investor attention in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock's performance today highlights its potential for investors seeking opportunities in smaller-cap stocks.

The price action today was accompanied by a total trading volume of 430,447 shares, significantly higher than usual, indicating increased market interest. The stock opened at Rs 37.01 and reached a high of Rs 41.71, demonstrating strong upward momentum throughout the trading session. This price movement reflects investor optimism and positions Medico Remedies Ltd. as a noteworthy player in its industry.

Medico Remedies Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 41.71
Previous Close	Rs 38.2
Today's Change	+Rs 3.51 (+9.19%)
Day Open	Rs 37.01
Day High	Rs 41.71
Day Low	Rs 37.01
Current Volume (BSE)	13,392
BSE Traded Volume	13,392
NSE Traded Volume	4,17,055
Combined NSE + BSE Volume	4,30,447
Turnover	Rs 0.06 crore
Market Capitalisation	Rs 317 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today's trading session saw Medico Remedies Ltd. Share Price rise to Rs 41.71, a 9.19% increase from the previous close of Rs 38.2. The stock opened at Rs 37.01 and reached a high of Rs 41.71, with a low of Rs 37.01. The turnover for the day was Rs 0.06 crore, with a total volume of 430,447 shares traded across BSE and NSE. This volume is significantly higher than the average, indicating strong market participation.

As a micro-cap stock, Medico Remedies Ltd. cleared the qualifying threshold of 8.1% for a significant price rise. The company's market capitalisation stands at Rs 317 crore, placing it in the micro-cap category. Today's rally underscores the stock's potential to attract investor interest, especially given the increased trading activity and positive price movement.

The Healthcare sector, particularly the Pharmaceuticals & Drugs industry, has been a focal point for investors, and Medico Remedies Ltd.'s performance today aligns with this trend. The stock's price action suggests a growing interest in the company's prospects, warranting further analysis of its technical and fundamental aspects.

Medico Remedies Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 317 crore
P/E Ratio	24.17x
P/B Ratio	4.2x
ROE	8.31%
ROCE	10.13%
EPS	Rs 1.58
Book Value Per Share	Rs 9.1
Dividend Yield	0%

Medico Remedies Ltd. was valued at a P/E ratio of 24.17x, a P/B ratio of 4.2x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 8.31% and ROCE of 10.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 1.58, book value per share of Rs 9.1, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Medico Remedies Ltd. has a market capitalisation of Rs 317 crore and an enterprise value that reflects its position in the Healthcare sector. The company's P/E ratio stands at 24.17, which is above the industry median of 18.45 but below the average of 57.26, indicating a moderate valuation relative to its peers. The P/B ratio is 4.2, significantly higher than the industry median of 1.83, suggesting a premium valuation on its book value.

The company's return on equity (ROE) is 8.31%, slightly below the industry median of 9.68%, while the return on capital employed (ROCE) is 10.13%, also below the industry median of 12.57%. These figures indicate that while the company is generating returns, there is room for improvement compared to its industry peers.

Medico Remedies Ltd. has an earnings per share (EPS) of Rs 1.58 and a book value per share of Rs 9.1. The company does not currently offer a dividend yield, which may be a consideration for income-focused investors. Overall, the fundamental analysis suggests that while the company is performing adequately, there are areas where it could enhance its financial metrics to align more closely with industry benchmarks.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Companies in Benchmark	140
Company P/E Ratio	24.17x
Benchmark Median P/E	18.45x
Benchmark Average P/E	57.26x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	140
Company P/B Ratio	4.2x
Benchmark Median P/B	1.83x
Company ROE	8.31%
Benchmark Median ROE	9.68%
Company ROCE	10.13%
Benchmark Median ROCE	12.57%
Company Market Capitalisation	Rs 317 crore
Benchmark Median Market Cap	Rs 145.95 crore

Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs. The numerical benchmark uses 140 same industry companies from the supplied master-data set.

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 24.17x, which is above the benchmark median of 18.45x, a difference of +31%. The benchmark contains 140 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Medico Remedies Ltd. (MEDICO) has a ROE of 8.31%, which is below the benchmark median of 9.68%, a difference of -14.15%. Medico Remedies Ltd. (MEDICO) has a ROCE of 10.13%, which is below the benchmark median of 12.57%, a difference of -19.41%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector, particularly the Pharmaceuticals & Drugs industry, comprises 140 companies, with Medico Remedies Ltd. being one of them. The industry has a wide range of P/E ratios, from 0 to 3482.29, with a median of 18.45. Medico Remedies Ltd.'s P/E ratio of 24.17 places it above the median, indicating a relatively higher valuation compared to many of its peers.

The industry also shows a diverse range of P/B ratios, with Medico Remedies Ltd.'s 4.2 being significantly higher than the median of 1.83. This suggests that the company is valued at a premium relative to its book value compared to the industry average. The company's ROE of 8.31% and ROCE of 10.13% are below the industry medians of 9.68% and 12.57%, respectively, indicating potential areas for improvement in profitability and capital efficiency.

With a market capitalisation of Rs 317 crore, Medico Remedies Ltd. is positioned below the industry median of Rs 145.95 crore, highlighting its status as a smaller player in the sector. Despite this, the company's recent price action and valuation metrics suggest that it remains a compelling option for investors seeking exposure to the Healthcare sector.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Trident Lifeline Ltd.	TLL	313.3	16.45	3.38	0	33.7
Medicamen Biotech Ltd.	MEDICAM	328.49	34.07	1.22	9.89	12.99
BDH Industries Ltd.	BDH	339.57	31.4	4.49	16.26	18.74
iStreet Network Ltd.	ISTRNETWK	345.25	69.58	7.36	0	0
Everest Organics Ltd.	EVERESTO	289.59	52.22	3.64	33.96	33.76

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 24.17x compared with the displayed peer median of 34.07x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.31% compares with a peer median of 9.89% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 18.74%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 317 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

In comparison to its peers, Medico Remedies Ltd. has a P/E ratio of 24.17, which is higher than Trident Lifeline Ltd.'s 16.45 but lower than Medicamen Biotech Ltd.'s 34.07. The company's P/B ratio of 4.2 is higher than Trident Lifeline Ltd.'s 3.38 and Medicamen Biotech Ltd.'s 1.22, indicating a premium valuation on its book value.

Medico Remedies Ltd.'s ROE of 8.31% is lower than Medicamen Biotech Ltd.'s 9.89% but higher than Trident Lifeline Ltd., which has a ROE of 0. The company's ROCE of 10.13% is below Medicamen Biotech Ltd.'s 12.99% but above Trident Lifeline Ltd.'s 33.7%. These comparisons highlight Medico Remedies Ltd.'s relative strengths and weaknesses within the Pharmaceuticals & Drugs industry.

Why Investors Are Watching Medico Remedies Ltd.

Investors are closely monitoring Medico Remedies Ltd. due to its recent price surge and position within the Healthcare sector. The company's performance today has highlighted its potential as a micro-cap stock with growth opportunities.

• Price Action: 9.19% increase to Rs 41.71.
• Technical Position: Strong upward momentum.
• Fundamental Context: Moderate valuation with room for improvement.
• Sector Positioning: Active in the Pharmaceuticals & Drugs industry.

Investors should continue to monitor Medico Remedies Ltd.'s financial performance and market trends to assess its potential for future growth.

About Medico Remedies Ltd.

Medico Remedies Ltd. operates within the Pharmaceuticals & Drugs industry, focusing on the development and manufacturing of pharmaceutical products. The company is part of the broader Healthcare sector, which includes a diverse range of companies engaged in the production and distribution of medical products and services.

Medico Remedies Ltd. is known for its commitment to quality and innovation, striving to meet the healthcare needs of its customers. The company's product portfolio includes a variety of pharmaceutical formulations, catering to different therapeutic areas. As a micro-cap company, Medico Remedies Ltd. is positioned to leverage its expertise and expand its market presence within the competitive Pharmaceuticals & Drugs industry.

Track Medico Remedies Ltd. Share Price on Univest

Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Medico Remedies Ltd. Share Price on Univest to stay updated on live price movements, technical indicators, and fundamental ratios. Univest provides comprehensive market insights, including shareholding patterns, 52-week levels, and industry trends, helping investors make informed decisions.

Frequently Asked Questions

How much did Medico Remedies Ltd. share price increase today?

Ans. The share price of Medico Remedies Ltd. increased by 9.19% today, closing at Rs 41.71. The stock moved 9.19% during the session. The intraday range extended from Rs 37.01 to Rs 41.71.

What is the market capitalisation of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a market capitalisation of Rs 317 crore, categorising it as a micro-cap stock. The company operates in the Healthcare sector. Its P/E ratio is 24.17x. ROE is 8.31% and ROCE is 10.13%.

What is the P/E ratio of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a P/E ratio of 24.17, which is above the industry median of 18.45. The company trades at a P/E ratio of 24.17x. Its P/B ratio is 4.2x.

How does Medico Remedies Ltd.'s P/B ratio compare to the industry?

Ans. The P/B ratio of Medico Remedies Ltd. is 4.2, significantly higher than the industry median of 1.83. The company trades at a P/E ratio of 24.17x. Its P/B ratio is 4.2x.

What is the ROE of Medico Remedies Ltd.?

Ans. Medico Remedies Ltd. has a return on equity (ROE) of 8.31%, slightly below the industry median of 9.68%. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 9.68%.

What is the ROCE of Medico Remedies Ltd.?

Ans. The return on capital employed (ROCE) for Medico Remedies Ltd. is 10.13%, below the industry median of 12.57%. ROE stands at 8.31%. ROCE stands at 10.13%. The relevant peer median ROE is 9.68%.

What sector does Medico Remedies Ltd. operate in?

Ans. Medico Remedies Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs. 140 comparable companies were included in the benchmark.

Who are some of Medico Remedies Ltd.'s peers?

Ans. Peers of Medico Remedies Ltd. include Trident Lifeline Ltd., Medicamen Biotech Ltd., and BDH Industries Ltd., among others. Comparable listed companies include Trident Lifeline Ltd., Medicamen Biotech Ltd., BDH Industries Ltd.